vTv Therapeutics (VTVT) – Analyst EPS View
-
Piper Jaffray Reiterates Overweight Rating and $24 PT on vTv Therapeutics (VTVT) Following Positive GK Activator T2D Presentation
-
UPDATE: Canaccord Genuity Starts vTv Therapeutics (VTVT) at Buy
Back to VTVT Stock Lookup